Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Giraudo Bryan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-07-15
Purchase
2022-07-15
4:23 pm
Gossamer Bio Inc.GOSSGiraudo Bryan
COO/CFO
13,869$7.21$99,995120,157
(Indirect
Direct)
View
2022-03-23
Sale
2022-03-24
4:53 pm
Gossamer Bio Inc.GOSSGiraudo Bryan
COO/CFO
10,722$8.915$95,587106,288
(Indirect
Direct)
View
2021-03-23
Sale
2021-03-25
4:11 pm
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
5,490$9.4801$52,046117,010
(Indirect
Direct)
View
2020-10-14
Purchase
2020-10-14
7:27 pm
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
3,000$10.01$30,03677,500
(Indirect
Direct)
View
2020-06-23
Purchase
2020-06-23
5:01 pm
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
2,000$12.96$25,92274,500
(Indirect
Direct)
View
2019-12-03
Purchase
2019-12-03
6:46 pm
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
8,000$5.7025$45,62018,000
(Indirect
Direct)
View
2019-09-26
Purchase
2019-09-26
4:08 pm
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
1,121$16.78$18,81026,000
(Indirect
Direct)
View
2019-05-30
Purchase
2019-06-03
4:03 pm
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
1,000$18.7$18,70024,879
(Indirect
Direct)
View
2019-02-12
Purchase
2019-02-12
5:33 pm
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
6,000$16$96,00023,879
(Direct)
View
2018-05-15
Purchase
2018-05-17
5:48 pm
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
10,000$6.4566$64,56634,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-16
Option Award
2023-01-18
8:13 pm
N/A
2033-01-15
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
30,000$030,000
(Direct)
View
2022-12-07
Option Award
2022-12-09
5:15 pm
N/A
2032-12-06
Gossamer Bio Inc.GOSSGiraudo Bryan
COO/CFO
211,500$0211,500
(Direct)
View
2022-05-26
Option Award
2022-05-27
4:00 pm
N/A
2032-05-26
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
20,000$020,000
(Direct)
View
2022-01-06
Option Award
2022-01-10
4:05 pm
N/A
2032-01-05
Gossamer Bio Inc.GOSSGiraudo Bryan
COO/CFO
265,000$0265,000
(Direct)
View
2021-09-16
Option Award
2021-09-20
4:25 pm
N/A
2031-09-16
Gossamer Bio Inc.GOSSGiraudo Bryan
COO/CFO
150,000$0150,000
(Direct)
View
2021-05-27
Option Award
2021-05-28
6:39 pm
N/A
2031-05-26
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
18,000$018,000
(Direct)
View
2021-02-25
Option Award
2021-03-01
4:50 pm
N/A
2031-02-25
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
135,000$0212,500
(Direct)
View
2020-05-28
Option Award
2020-05-29
6:12 pm
N/A
2030-05-27
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
15,000$015,000
(Direct)
View
2020-02-14
Option Award
2020-02-19
4:20 pm
N/A
2030-02-14
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
118,000$0144,000
(Direct)
View
2019-06-07
Option Award
2019-06-11
6:20 pm
N/A
2029-06-06
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
12,000$012,000
(Direct)
View
2019-03-25
Option Award
2019-03-26
6:45 pm
N/A
2029-03-25
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
145,000$0145,000
(Direct)
View
2019-02-12
Conversion
2019-02-12
5:33 pm
N/A
N/A
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
98,337$023,879
(Direct)
View
2019-02-07
Ownership
2019-02-07
7:07 pm
N/A
N/A
Gossamer Bio Inc.GOSSGiraudo Bryan
Chief Financial Officer
0$0579,100
(Direct)
View
2018-05-29
Option Award
2018-06-12
6:39 pm
N/A
2028-05-28
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
12,000$012,000
(Direct)
View
2018-05-15
Option Award
2018-05-17
5:48 pm
N/A
2028-05-14
Protagonist Therapeutics IncPTGXGiraudo Bryan
Director
24,000$034,000
(Direct)
View